| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/17/2007 | US7244433 Immunogens; replication-defective; antibodies; host cells; kits |
| 07/17/2007 | US7244423 delivery of a neurotrophin to targeted defective, diseased or damaged cholinergic neurons |
| 07/17/2007 | US7244422 Enhancing the effect of hepatitis vaccines, particularly hepatitus B vaccines, by the use of ribavirin as an adjuvant; single administration |
| 07/17/2007 | US7244410 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 07/17/2007 | CA2305655C Self-deleting vectors for cancer therapy |
| 07/17/2007 | CA2283198C Butyrate prodrugs derived from lactic acid |
| 07/17/2007 | CA2231436C Neural transplantation using pluripotent neuroepithelial cells |
| 07/17/2007 | CA2145535C Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain |
| 07/12/2007 | WO2007079390A2 Medicament for topical use |
| 07/12/2007 | WO2007079351A2 Novel prime-boost combinations of attenuated mycobacterium |
| 07/12/2007 | WO2007079128A1 Na+, k+-atpase expression in cervical dysplasia and cancer |
| 07/12/2007 | WO2007058992A3 Mutations and polymorphisms of hdac6 |
| 07/12/2007 | WO2007058663A3 Recombinant bcg strains with enhanced ability to escape the endosome |
| 07/12/2007 | WO2007053184A3 Methods for producing micrornas |
| 07/12/2007 | WO2007044394A3 Compositions and methods for treatment of autoimmune disease |
| 07/12/2007 | WO2007016501A3 Compositions and method for brain specific targeted delivery of therapeutic agents |
| 07/12/2007 | WO2007014033A3 Inhibition of extracellular signal-regulated kinase 1/2 as a treatment for cardiac hypertrophy and heart failure |
| 07/12/2007 | WO2006089001A3 Lentiviral vectors and their use |
| 07/12/2007 | WO2006063072A3 Immunomodulatory compositions, combinations and methods |
| 07/12/2007 | WO2005037232A3 Methods and compositions for modulating adipocyte function |
| 07/12/2007 | WO2005027962A3 4’-thionucleosides and oligomeric compounds |
| 07/12/2007 | US20070162994 Pseudomonas avr and hop proteins, their encoding nucleic acids, and use thereof |
| 07/12/2007 | US20070162987 Modulation of body weights; dietetics; eating disorders; for diagnostic and therapeutic implications in homeostasis of body weight and adipose tissue mass |
| 07/12/2007 | US20070161596 Study and interfererance, diagnosis and treatment of polyglutamine using short interfering nucleic acid for treatment of dementia or siezures or muscular dystrophy |
| 07/12/2007 | US20070161595 downregulation of the alpha-synuclein gene for the treatment of synucleinopathies; iRNA agents |
| 07/12/2007 | US20070161594 Compositions and their uses directed to il-4r alpha |
| 07/12/2007 | US20070161593 Compositions and their uses directed to il-4r alpha |
| 07/12/2007 | US20070161592 Method of treating fear |
| 07/12/2007 | US20070161591 Methods and compositions for treating neurological disease |
| 07/12/2007 | US20070161590 Methods and sequences to preferentially suppress expression of mutated huntingtin |
| 07/12/2007 | US20070161589 DNA, RNA or chimeric oligonucleotide that is at least 90% complementary the nucleic acid encoding CD40 antigens, used for inhibiting the expression of CD40 in cells or tissues; antitumor and antiproliferative agents |
| 07/12/2007 | US20070161588 Modulating cancer cell characteristics |
| 07/12/2007 | US20070161587 Cobalamin mediated delivery of nucleic acids, analogs and derivatives thereof |
| 07/12/2007 | US20070161586 Drug for preventing and treating atherosclerosis |
| 07/12/2007 | US20070161585 Immunopotentiator and method for enhancing immunoactivity using the same |
| 07/12/2007 | US20070161584 gene therapy of transferring the CD9 gene for suppressing cardiac hypertrophy or cardiac tachycardia in a patient having a heart disease; viral or non-viral expression vector containing a sequence encoding a CD9 protein |
| 07/12/2007 | US20070161582 Pharmaceutical compositions and methods for metabolic modulation |
| 07/12/2007 | US20070161562 Targeting of long chain triacylglycerol hydrolase gene for tuberculosis treatment |
| 07/12/2007 | US20070161560 Use of vanilloid 4 receptor and antagonists or agonists thereof for treating diseases associated with pain |
| 07/12/2007 | US20070161556 Antifungal Therapeutic targets |
| 07/12/2007 | US20070161554 Treatment of neurodegenerative diseases by the use of laptm4b |
| 07/12/2007 | US20070161549 Glycosylation-deficient hepatocyte growth factor |
| 07/12/2007 | US20070161548 diagnosing a pregnant woman at increased risk of preeclampsia; HELLP (hemolysis, elevated liver enzymes; contacting the sample with an antibody that specifically binds a marker |
| 07/12/2007 | US20070161547 Modulation of survivin expression |
| 07/12/2007 | US20070161083 Codon Optimized Recombinant Dermaphagoides Allergens |
| 07/12/2007 | US20070161080 Antibodies |
| 07/12/2007 | US20070161021 Novel nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPase |
| 07/12/2007 | US20070161019 Method for detecting cancer and a method for suppressing cancer |
| 07/12/2007 | US20070161002 Growth differentiation factor promoter and uses therefor |
| 07/12/2007 | US20070160980 Each double stranded siNA sequence is between 19 and 23 nucleotides, directs gene cleavage, has a complementary antisense region, and is derived from a virus chosen from HIV, hepatitis, respiratory syncytial virus (RSV) or influenza; gene therapy |
| 07/12/2007 | US20070160658 Delivery system for diagnostic and therapeutic agents |
| 07/12/2007 | US20070160632 Polyinosinic acid-polycytidylic acid-based adjuvant |
| 07/12/2007 | US20070160624 Peptides of the Bacillus anthracis Anthrax Toxin Lethal factor Protein pX01-107; methods of stimulating immune response; antisense agents; vaccine |
| 07/12/2007 | US20070160620 Immune responses using compositions containing stress proteins |
| 07/12/2007 | US20070160612 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 07/12/2007 | US20070160588 Treatment Of Peripheral Vascular Disease Using Postpartum-Derived Cells |
| 07/12/2007 | US20070160587 Allogeneic tumor therapeutic agent, a vaccine using allogeneic tumor cells for the therapeutic treatment of tumor diseases, and a method for the making of such a vaccine, and transfected human tumor cells for use as a vaccine |
| 07/12/2007 | US20070160586 Methods for extending the replicative lifespan of cells |
| 07/12/2007 | US20070160585 Remedy for prion disease and method of producing the same |
| 07/12/2007 | US20070160581 Production of ssDNA in vivo |
| 07/12/2007 | US20070160579 Methods of modulating a mammalian cytokine |
| 07/12/2007 | US20070160575 Anth1 chimeric antagonist |
| 07/12/2007 | US20070160545 Method for reducing ultraviolet light induced apoptosis |
| 07/12/2007 | US20070160531 Targeting endothelium for tissue-specific delivery of agents |
| 07/12/2007 | US20070160526 Detection, monitoring and treatment of cancer |
| 07/12/2007 | CA2635992A1 Medicament for topical use |
| 07/12/2007 | CA2634896A1 Na+, k+-atpase expression in cervical dysplasia and cancer |
| 07/12/2007 | CA2634334A1 Interfering rnas targeting the morbillivirus nucleoprotein gene |
| 07/11/2007 | EP1806407A2 DNA sequences having anti-repressor activity |
| 07/11/2007 | EP1806360A2 Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease |
| 07/11/2007 | EP1806357A1 Hypoxia inducible factor-1 and method of use |
| 07/11/2007 | EP1806354A2 Amphoteric sterols and their use |
| 07/11/2007 | EP1806353A1 Antisense modulation of novel anti-apoptotic BCL-2-related proteins |
| 07/11/2007 | EP1806147A1 Use of immunesuppressant receptor |
| 07/11/2007 | EP1806144A2 Use of SARP-1 for the treatment and/or prevention of scleroderma |
| 07/11/2007 | EP1804839A2 Improved expression of factor ix in gene therapy vectors |
| 07/11/2007 | EP1639029B1 Biodegradable poly(beta-amino esters) and uses thereof |
| 07/11/2007 | EP1370666B1 Genetic immunisation against cervical carcinoma |
| 07/11/2007 | EP1206284B1 Method for delivery of therapeutic agents using a solution of dextrin |
| 07/11/2007 | EP1065270B1 HUMAN p51 GENES AND GENE PRODUCTS THEREOF |
| 07/11/2007 | EP0904352B1 Cell line |
| 07/11/2007 | EP0857208B1 Chimaeric oligonucleotides and uses thereof in the identification of antisense binding sites |
| 07/11/2007 | EP0815214B1 Dna molecules, preparation thereof and use thereof in gene therapy |
| 07/11/2007 | CN1997746A Chimeric adenoviruses for use in cancer treatment |
| 07/11/2007 | CN1995356A Fusion gene vector construction and expression as well as uses |
| 07/11/2007 | CN1995354A Mycobacterium tuberculosis succinyl coenzymea A synthase gene and its uses |
| 07/11/2007 | CN1995352A Mycobacterium tuberculosis cold-shock protein and its uses |
| 07/11/2007 | CN1995335A Tubercle bacillus rhodanase and its uses |
| 07/11/2007 | CN1994470A Genetic engineering polypeptide vaccine adjuvant for aftosa, preparation method and application thereof |
| 07/11/2007 | CN1325653C Retroviral delivery system |
| 07/11/2007 | CN1325650C Delivery system for porcine somatotropin |
| 07/11/2007 | CN1325647C Selectively replicating viral vectors |
| 07/11/2007 | CN1325646C Modified nucleic acid sequences and method for increasing mRNA levels and protein expression in cell systems |
| 07/11/2007 | CN1325645C Histamine and serotonin binding molecules |
| 07/11/2007 | CN1325643C Oligonucleotides modulating expression of enzymes involved in synthesis of melanic pigments |
| 07/10/2007 | US7241882 Polyamide nucleic acid derivatives, and agents, and processes for preparing them |
| 07/10/2007 | US7241876 Compositions and methods for the therapy and diagnosis of breast cancer |
| 07/10/2007 | US7241869 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 07/10/2007 | US7241744 Delivering into cells of the subject an effective amount of a nucleic acid expression construct that encodes a growth-hormone-releasing-hormone ("GHRH") or functional biological equivalent thereof for therapy of anemia |
| 07/10/2007 | US7241742 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferative disorders |